Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high1,187.0 01/11/17
52 week low700.0 16/12/16
52 week change 309.5 (42.78%)
4 week volume8,526,469 21/11/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Clinigen director steps down

Clinigen Group director Chris Rigg has resigned with immediate effect to seek a chief executive role elsewhere. Clinigen CE...

Directorate Change

RNS Number: 4871Y Clinigen Group plc 06 December 2017 6 December 2017 Directorate Change Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere. Shaun Chilton, CEO of Clinigen, said: "On behalf of the B...

Clinigen in equity issue

Clinigen Group issued 17,925 ordinary shares yesterday to satisfy share options vesting under the group's all staff long term...

Issue of Equity

RNS Number: 3549Y Clinigen Group plc 04 December 2017 4 December 2017 Issue of Equity Clinigen Group plc (AIM: CLIN, the "Group") announces that it has made an application for the admission to trading on AIM of 17,925 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"). These ordinary shares have been issued to satisfy share option...

Total Voting Rights

RNS Number: 8937X Clinigen Group plc 30 November 2017 30 November 2017 Clinigen Group plc ("Clinigen" or the "Group") Total Voting Rights and Capital In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Group notifies the market that as at 30 November 2017 Clinigen's issued share capital consists of 122,268,158 ordinary shar...

Broker Forecast - N+1 Singer issues a broker note on Clinigen Group

N+1 Singer today reaffirms its buy investment rating on Clinigen Group (LON:CLIN) and set its price target at 1225p.

All resolutions passed at AGM of Clinigen

Clinigen Group has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:04p...

Result of AGM

RNS Number: 7459X Clinigen Group plc 28 November 2017 28 November 2017 Result of AGM Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, held its Annual General Meeting ("AGM") at 10.00am today.All resolutions were passed. At the meeting, Peter Allen, Clinigen's Chairman reiterated that the Group is ...

Fundamental DataMore

P/E ratio313.03
EPS3.3
Dividend yield0.484 %

Latest discussion posts More

  • Todays RNS

    HMMMMmmmmmm ??? I am lost for words Why wasn't he made to stay... Either they realised that he would be an overpaid director doing practically nothing.. Alternatively ...
    6-Dec-2017
    up protherics
  • Qp share holders

    Looks like QP shareholders have been very truly sucked in by the spiv brigade. Nice issue of equity together with the ramping of the price the day they were issued.. INMO ...
    5-Dec-2017
    up protherics
  • share options

    Are there any white crime lawyers out there. Preferably U,S ones and not the spiv brigade that are involved with envelope and his building brigade Great RNS INMO Could ...
    18-Nov-2017
    up protherics

Users' HoldingsMore

Users who hold Clinigen Group also hold..

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account